Large HDL Particle Count and Your Genetics

By the ExomeDNA Research Team | Reviewed by the ExomeDNA Editorial Process | Last reviewed: May 2026

Large HDL particle count is an NMR-measured lipoprotein subclass biomarker reflecting the circulating concentration of the largest high-density lipoprotein particles — a subclass characterized by greater cholesterol content per particle and active involvement in reverse cholesterol transport. Unlike total HDL cholesterol, which aggregates all HDL size classes, the large HDL subclass specifically captures the biggest circulating HDL particles. This page examines the genetic contributors to large HDL particle count, including endothelial lipase (LIPG) and ACAA2, and what current research reveals about the inherited basis of this lipoprotein subclass.

What is large HDL particle count?

Large HDL particle count is measured using nuclear magnetic resonance (NMR) spectroscopy of a blood sample, a technique that distinguishes HDL particles by size rather than reporting only total cholesterol mass. High-density lipoprotein particles range from small to large subclasses, and the larger subclasses carry more cholesterol per particle and are thought to be particularly active in cholesterol efflux from arterial macrophages. The genetic research on large HDL particle count remains at an earlier stage than that on total HDL cholesterol, with current evidence drawing primarily on metabolomics cohort studies using NMR technology in carefully phenotyped populations.

The genetics behind large HDL particle count

Genome-wide research has identified a focused set of genetic loci contributing to large HDL particle concentration, reflecting the trait's specificity as a size-selected lipoprotein subclass with a narrower genetic footprint than total HDL cholesterol.

LIPG — Endothelial lipase is a member of the triglyceride lipase family that is specifically expressed on vascular endothelial cells and in the liver. Unlike lipoprotein lipase (LPL), which hydrolyzes triglycerides in VLDL, LIPG primarily targets phospholipids in HDL particles, cleaving the phospholipid shell and causing HDL particles to shrink in size. Variants that reduce LIPG activity are associated with larger, more phospholipid-rich HDL particles — making LIPG a direct regulator of HDL particle size distribution. Studies have associated LIPG variants with differences in HDL subclass profiles and cardiovascular risk.

ACAA2 — Encodes acetyl-CoA acyltransferase 2, the enzyme that catalyzes the final step in the mitochondrial fatty acid beta-oxidation spiral, releasing acetyl-CoA from fatty acid chains. ACAA2's association with large HDL particle count suggests a connection between mitochondrial lipid catabolism — the cellular machinery for extracting energy from fatty acids — and the concentration of large HDL particles in circulation. The specific pathway linking ACAA2 activity to large HDL production is an area of ongoing investigation.

CTIF — A component of the CBP80/CBP20 mRNA translation initiation complex involved in cotranscriptional translation of nascent mRNA. CTIF's association with large HDL particle count reflects the early-stage nature of this research area, where some identified genes point to unexpected biological pathways that await further mechanistic characterization.

Genome-wide analysis in Finnish men using NMR metabolomics identified 12 genetic loci associated with large HDL particle concentration, with endothelial lipase (LIPG) and ACAA2 among the genes with the strongest proximity to the top association signals for this lipoprotein subclass. (Davis et al., 2017)^[1]

The limited number of robust loci for large HDL particle count, compared to the hundreds identified for total HDL cholesterol, reflects both the recency of NMR-based lipoprotein subclass research and the biological specificity of the size-selected phenotype being measured.

What the research says about large HDL particle count genetics

Davis et al. (2017), published in PLoS Genetics, examined common, low-frequency, and rare genetic variants associated with lipoprotein subclasses and triglyceride measures in Finnish men from the METSIM (METabolic Syndrome In Men) study using NMR metabolomics. The METSIM study was among the early large-scale efforts to apply NMR metabolomics to lipoprotein subclass genetics, identifying associations specific to particle size subclasses rather than just total lipid concentrations.

Research in a Finnish metabolomics cohort identified endothelial lipase (LIPG) — a phospholipase involved in lipoprotein metabolism and vascular biology — among the genetic contributors to large HDL particle concentration, consistent with LIPG's known role in reducing HDL particle size through phospholipid hydrolysis. (Davis et al., 2017)^[1]

The focus on Finnish men in the METSIM study reflects the research value of genetically homogeneous populations for variant discovery. However, replication of large HDL particle loci in diverse ancestry cohorts is limited at this stage, and the current evidence base for large HDL particle count genetics should be interpreted as preliminary findings awaiting broader validation.

How large HDL particle count affects you

Studies have associated higher concentrations of large HDL particles with active involvement in reverse cholesterol transport, though the evidence base for large HDL particle count specifically is more limited than that for total HDL cholesterol. The large HDL subclass is of scientific interest because larger particles carry more cholesterol per unit and may be more effective at extracting cholesterol from macrophages in arterial tissue.

Individual large HDL particle levels reflect both the total HDL production pathway and the size-modifying activity of enzymes like LIPG. People with genetic profiles affecting LIPG activity may have different HDL size distributions regardless of their total HDL cholesterol level. Regular aerobic exercise, which increases LPL activity and HDL production, tends to shift the HDL distribution toward larger particles in addition to raising total HDL cholesterol.

Working with your large HDL particle count profile

Because large HDL particle count reflects a size-specific subclass of total HDL, lifestyle factors that support higher total HDL also tend to support larger HDL particle concentrations:

• Regular aerobic exercise: Consistent moderate-to-vigorous aerobic activity is the most robustly documented lifestyle factor for raising both total HDL and shifting the distribution toward larger HDL particles through enhanced LPL-driven HDL maturation.
• Dietary fat quality: Replacing saturated fats with monounsaturated and polyunsaturated fats supports HDL remodeling toward larger, more cholesterol-rich particles in dietary intervention studies.
• Reducing refined carbohydrates: High-carbohydrate diets, particularly with refined sugars, are associated with smaller HDL particles in population studies; reducing refined carbohydrates supports a favorable HDL particle size profile.
• Body composition: Reduction of abdominal fat mass is associated with shifts toward larger HDL particles alongside increases in total HDL cholesterol in weight management studies.

Related traits and genes

Large HDL particle count sits within a suite of NMR-measured lipoprotein subclass traits that together characterize the full HDL size distribution: very large, large, medium, and small HDL subclasses each reflect different aspects of the reverse cholesterol transport system. Total HDL cholesterol (the mass-based measure) and total HDL particle count (the total number of HDL particles regardless of size) provide complementary perspectives on the same biological system.

LIPG's phospholipase activity connects large HDL genetics to vascular biology: LIPG is expressed on the endothelial surface and its activity influences HDL remodeling within the vascular compartment, linking lipoprotein metabolism to arterial wall function.

Explore total HDL cholesterol, HDL particle count, and triglycerides alongside large HDL particle count for the most complete view of your inherited lipoprotein profile.

Frequently asked questions

Q: How is large HDL particle count different from total HDL cholesterol? A: Total HDL cholesterol (HDL-C) measures the combined mass of cholesterol carried within all HDL particles of all sizes, expressed in mg/dL or mmol/L. Large HDL particle count specifically measures the number of the largest HDL size class, as distinguished by NMR spectroscopy. A person can carry the same total HDL-C but differ substantially in the proportion of large versus small particles.

Q: What does endothelial lipase (LIPG) do to HDL particles? A: LIPG is expressed on the surface of vascular endothelial cells and specifically hydrolyzes phospholipids in the outer shell of HDL particles. When LIPG activity is elevated, HDL particles lose phospholipids and shrink — reducing the proportion of large HDL in circulation. Variants that reduce LIPG activity are associated with larger, more phospholipid-rich HDL particles.

Q: Why is the evidence for large HDL particle count genetics more limited than for total HDL? A: Large HDL particle count is measured by NMR metabolomics, a technology that became widely available for genetic research more recently than standard lipid panel measurements. Fewer large-scale studies and less replication across diverse populations exist compared to total HDL cholesterol, which has been studied for decades in millions of participants.

Q: Can lifestyle changes increase the proportion of large HDL particles? A: Research suggests that regular aerobic exercise increases HDL particle size toward the larger subclasses in addition to raising total HDL. Reducing refined carbohydrate intake and achieving a healthy body weight are also associated with larger mean HDL particle size in population studies.

Q: What is the METSIM study and why was it important for large HDL genetics? A: METSIM (METabolic Syndrome In Men) is a Finnish male cohort study that applied NMR metabolomics to characterize lipoprotein subclasses including large HDL particles at the genetic level. Finnish population studies have research value due to genetic homogeneity and thorough phenotyping, enabling discovery of lipoprotein subclass variants that would be harder to detect in more heterogeneous populations. METSIM's large HDL particle findings provided an initial genetic map awaiting replication in broader cohorts.

Research base: Moderate.

By the ExomeDNA Research Team | Reviewed by the ExomeDNA Editorial Process | Last reviewed: May 2026

ExomeDNA genetic analysis is for wellness and educational purposes only and is not intended to serve as a clinical tool or health intervention.

References

1. Davis JP et al. (2017). Common, low-frequency, and rare genetic variants associated with lipoprotein subclasses and triglyceride measures in Finnish men from the METSIM study. PLoS Genetics. PMID:29084231.

Data sources: ExomeDNA large HDL particle count genetic analysis draws on variant associations from genome-wide association study databases, ClinVar variant classifications, and publicly available NCBI gene annotation data.